Join Intertek at the 2026 BIO International Convention

Intertek, a leading Total Quality Assurance provider to industries worldwide, is proud to exhibit at the 2026 BIO International Convention in San Diego, California, USA. BIO2026 is a premier global gathering for biotechnology and life sciences leaders, innovators, and stakeholders. It aims to unite the community to explore cutting-edge biotech innovations, advance public health, and foster collaboration across the industry.

Join us at Booth #5155 from June 22-25, 2026 to learn how Intertek supports drug development strategy, regulatory agency submissions and interactions, and risk and safety assessments.

Our experts will be on hand to discuss solutions that help you with:

• Integrated CMC, Nonclinical Toxicology & Clinical Drug Development Expertise
• Due Diligence, Gap Analysis, & Feasibility Assessments
• Global Regulatory Strategy, Planning & Agency Interactions
• Regulatory Affairs & Product Lifecycle Management
• Toxicological Risk Assessments (g. Impurities, E&L, Excipients, Health-Based Exposure Limits)
• Global Regulatory Submission Preparation and Publishing
• Medical and Scientific Writing
• Research Support and Issue Resolution

Meet our experts onsite:

• Bruce Connop, Vice President, Pharmaceuticals & Healthcare – Intertek Assuris
• Carolyn Hosannah, Senior Director, Regulatory Affairs, Pharmaceuticals & Healthcare – Intertek Assuris
• Alia Vaz, Associate Director, Toxicology, Strategy, and Development, Pharmaceuticals & Healthcare – Intertek Assuris

Interested in learning more or connecting with our experts?

Fill out the form below to contact our team and schedule a personalized discussion during BIO2026.